ArticleJournal of surgical case reports2026
Minimally invasive hyperthermic intraperitoneal chemotherapy at the time of interval cytoreductive surgery for ovarian cancer: a case report.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian cancer is the second most prevalent gynecologic cancer and the leading cause of death of all gynecologic malignancies. At the time of diagnosis, most patients have advanced-stage disease and neoadjuvant chemotherapy may be used in these patients to increase the chance of optimal cytoreductive surgery (CRS). Hyperthermic intraperitoneal chemotherapy (HIPEC) at the time of interval CRS has been shown to improve both recurrence free and overall survival in eligible patients. We present a case of a patient with a BMI of 54 who underwent a minimally invasive interval cytoreduction followed by HIPEC. This case demonstrates that minimally invasive HIPEC using standard equipment is safe, feasible, and cost effective.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.